ARCHIVES

FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug

This article is from The Cancer Letter archive.

Vol. 36 No. 7 | July 26, 2013

Download PDF Visit The Full Archive

Related Articles

Survival After Liver Transplant Called Excellent In Study

November 28, 2003

Alcohol Consumption Increases Risk Of Lobular And HR+ Breast Cancer

August 27, 2010

In Brief: $100 Million Being Spent On Interferon In U.S., Rauscher Says; DeVita; Criticism Deserved

April 4, 1980

In Brief: Hammer Appointed To New Three Year Term, Says As Panel Chairman; ACCC Elects Yarbro, Moorhead

March 16, 1984

NCI Revises Procedure for Contract Concept Review By Advisors

September 6, 1996

Healthy Weight, Lower Stress May Result In Fewer Changes Associated With Aging

March 27, 2009